APA (7th ed.) Citation

N, K., N, D., L, L., S, T., F, G., S, B., . . . P, C. (2026). SG33, a Vaccine Strain of Myxoma Virus with Oncolytic Potential, Exploits Macropinocytosis and Clathrin-Mediated Endocytosis for Entry into Pancreatic Cancer Cells. Human gene therapy, 37(11-12), 500. https://doi.org/10.1177/10430342261441043

Chicago Style (17th ed.) Citation

N, Kontopoulos, Delenclos N, Ligat L, Top S, Gallardo F, Bertagnoli S, Dusetti N, Buscail L, and Cordelier P. "SG33, a Vaccine Strain of Myxoma Virus with Oncolytic Potential, Exploits Macropinocytosis and Clathrin-Mediated Endocytosis for Entry into Pancreatic Cancer Cells." Human Gene Therapy 37, no. 11-12 (2026): 500. https://doi.org/10.1177/10430342261441043.

MLA (9th ed.) Citation

N, Kontopoulos, et al. "SG33, a Vaccine Strain of Myxoma Virus with Oncolytic Potential, Exploits Macropinocytosis and Clathrin-Mediated Endocytosis for Entry into Pancreatic Cancer Cells." Human Gene Therapy, vol. 37, no. 11-12, 2026, p. 500, https://doi.org/10.1177/10430342261441043.